4//SEC Filing
Berkenblit Anna 4
Accession 0001415889-22-012990
CIK 0000855654other
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 5:13 PM ET
Size
8.0 KB
Accession
0001415889-22-012990
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Berkenblit Anna
VP & Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-11-14+222,300→ 333,450 totalExercise: $4.55From: 2022-11-14Exp: 2030-02-07→ Common Stock (222,300 underlying) - Award
Stock Option (Right to Buy)
2022-05-20+111,150→ 111,150 totalExercise: $4.55From: 2022-05-20Exp: 2030-02-07→ Common Stock (111,150 underlying)
Footnotes (2)
- [F1]On February 7, 2020, the reporting person was granted an option to purchase 444,600 shares of common stock. The option vests in installments upon the satisfaction of certain performance criteria. On May 20, 2022, certain performance criteria were met, resulting in the vesting of 25% of the performance stock option award.
- [F2]On February 7, 2020, the reporting person was granted an option to purchase 444,600 shares of common stock. The option vests in installments upon the satisfaction of certain performance criteria. On November 14, 2022, certain performance criteria were met, resulting in the vesting of 50% of the performance stock option award.
Documents
Issuer
ImmunoGen, Inc.
CIK 0000855654
Entity typeother
Related Parties
1- filerCIK 0001691868
Filing Metadata
- Form type
- 4
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 5:13 PM ET
- Size
- 8.0 KB